Clover received a notice from Nasdaq April 20 stating that its stock had closed below the minimum $1 per share threshold for 30 consecutive days. The company had until Oct. 17 to regain compliance.
To regain compliance, Clover’s stock needed to close at $1 or above for 10 consecutive business days. Clover met that requirement July 28, according to the filing.
“In light of this positive development, the Company will re-evaluate its options, including with respect to the reverse stock split and authorized share reduction proposal currently pending before the Company’s stockholders for approval at the special meeting of stockholders currently scheduled [Aug. 30],” Clover said in the filing.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
